Enliven Therapeutics Announces Closing of Upsized Public Offering of Common Stock and Pre-Funded Warrants and Full Exercise of the Underwriters' Option to Purchase Additional Shares
Go back to Enliven Therapeutics Announces Closing of Upsized Public Offering of Common Stock and Pre-Funded Warrants and Full Exercise of the Underwriters' Option to Purchase Additional Shares| (NASDAQ: ELVN) | Delayed: 45.96 +0.86 (1.91%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $45.10 | 52 Week High | $ | |||
| Open | $45.26 | 52 Week Low | $ | |||
| Day High | $48.52 | P/E | N/A | |||
| Day Low | $45.25 | EPS | $ | |||
| Volume | 2,517,152 | |||||
